BridgeBio Oncology Therapeutics, Inc.
BBOT- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001869105
No open-market purchases or sales by BridgeBio Oncology Therapeutics, Inc. insiders were filed in the last 90 days; 65 institutions reported holding it in 13F filings for Q2 2026, worth $450.6M in total; no superinvestor holds it.
13F holders, Q1 2025
Institutional positions in BridgeBio Oncology Therapeutics, Inc. as of Mar 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 31
- −1 vs. Q4 2024
- Shares held
- 16.5M
- +42.2K (+0.3%) vs. Q4 2024
- Total value
- $186.3M
- +$13.6M (+7.9%) vs. Q4 2024
- New holders
- 3
- 9 more added
- Sold out
- 4
- 6 more reduced
Compare with Q4 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting BBOT on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 65 | $450.6M |
| Q1 2026 | 67 | $513.8M |
| Q4 2025 | 52 | $724.7M |
| Q3 2025 | 42 | $657.5M |
| Q2 2025 | 34 | $177.6M |
| Q1 2025 | 31 | $186.3M |
| Q4 2024 | 32 | $172.7M |
| Q3 2024 | 31 | $171.1M |
| Q2 2024 | 31 | $167.4M |
| Q1 2024 | 29 | $166.9M |
| Q4 2023 | 0 | $0 |
| Q3 2023 | 0 | $0 |
| Q2 2023 | 0 | $0 |
| Q1 2023 | 0 | $0 |
| Q4 2022 | 0 | $0 |
| Q3 2022 | 0 | $0 |
| Q2 2022 | 0 | $0 |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q1 2025
Shares, value and share of portfolio for each institution holding BridgeBio Oncology Therapeutics, Inc.; share changes are against Q4 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Geode Capital Management, LLC | 13,274 | $150.0K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 92,660 | $1.05M | 0.00% | +57,712+165.1% | Added |
| Moore Capital Management, LP | 100,000 | $1.13M | 0.04% | 00.0% | Unchanged |
| K2 Principal Fund, L.P. | 100,000 | $1.13M | 0.17% | +100,000 | New |
| Woodline Partners LP | 103,247 | $1.17M | 0.01% | 00.0% | Unchanged |
| Toronto Dominion Bank | 138,000 | $1.56M | 0.00% | +88,500+178.8% | Added |
| TD Asset Management Inc | 144,772 | $1.64M | 0.00% | 00.0% | Unchanged |
| Soros Fund Management LLCSuperinvestorSoros Fund Management | 150,000 | $1.70M | 0.03% | −325,114−68.4% | Reduced |
| JPMorgan Chase & Co | 152,216 | $1.72M | 0.00% | +152,216 | New |
| Wellington Management Group LLP | 184,590 | $2.09M | 0.00% | 00.0% | Unchanged |
| Acuta Capital Partners, LLC | 187,257 | $2.12M | 2.45% | +6,312+3.5% | Added |
| Two Sigma Investments, LP | 189,285 | $2.14M | 0.00% | 00.0% | Unchanged |
| StemPoint Capital LP | 200,900 | $2.27M | 0.73% | 00.0% | Unchanged |
| Decagon Asset Management LLP | 239,403 | $2.71M | 2.45% | +52,949+28.4% | Added |
| Octagon Capital Advisors LP | 250,000 | $2.83M | 0.61% | 00.0% | Unchanged |
| Laurion Capital Management LP | 300,000 | $3.39M | 0.26% | 00.0% | Unchanged |
| Great Point Partners LLC | 373,833 | $4.22M | 2.30% | −126,167−25.2% | Reduced |
| Fort Baker Capital Management LP | 374,683 | $4.23M | 0.90% | +374,683 | New |
| T. Rowe Price Investment Management, Inc. | 397,962 | $4.50M | 0.00% | −2,285−0.6% | Reduced |
| Perceptive Advisors LLC | 398,000 | $4.50M | 0.16% | −102,000−20.4% | Reduced |
| ADAR1 Capital Management, LLC | 469,729 | $5.31M | 1.02% | +65,591+16.2% | Added |
| Harraden Circle Investments, LLC | 526,535 | $5.95M | 2.70% | +269,309+104.7% | Added |
| Farallon Capital Management, L.L.C. | 600,000 | $6.78M | 0.04% | 00.0% | Unchanged |
| Silverarc Capital Management, LLC | 613,393 | $6.93M | 1.45% | +100,024+19.5% | Added |
| Sculptor Capital LP | 800,000 | $9.04M | 0.20% | +95,000+13.5% | Added |
| Price T Rowe Associates Inc | 1,071,550 | $12.1M | 0.00% | −16,221−1.5% | Reduced |
| Millennium Management LLC | 1,096,382 | $12.4M | 0.01% | −45,920−4.0% | Reduced |
| Adage Capital Partners GP, L.L.C. | 1,400,000 | $15.8M | 0.03% | 00.0% | Unchanged |
| Citadel Advisors LLC | 1,411,960 | $16.0M | 0.02% | +72,290+5.4% | Added |
| BlackRock, Inc. | 1,498,865 | $16.9M | 0.00% | 00.0% | Unchanged |
| Cormorant Asset Management, LP | 2,909,000 | $32.9M | 2.49% | 00.0% | Unchanged |
| Commodore Capital LP | 0 | $0 | 0.00% | −500,000−100.0% | Sold out |
| Affinity Asset Advisors, LLC | 0 | $0 | 0.00% | −250,000−100.0% | Sold out |
| Gritstone Asset Management LLC | 0 | $0 | 0.00% | −24,666−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −1−100.0% | Sold out |